11 completed, 3 unknown, 2 recruiting, 1 terminated. 18 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 18 | Completed 11, Unknown 3, Recruiting 2, Terminated 1, Withdrawn 1 |
Follow Restenosis: new trials by email Literature Review of Restenosis trials Research Report on Restenosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravascular Ultrasound for Peripheral Artery Disease Revascularization IVUS-guided strategy - Peripheral Arterial Disease(PAD), Chronic Limb Threatening Ischemia | Not applicable | Recruiting | Hamilton Health Sciences Corporation | 772 | 2025-12-05 | 2026-09-18 |
| Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions Intravascular lithotripsy, Balloon - Coronary Angioplasty, Restenosis | Not applicable | Recruiting | University Hospital, Clermont-Ferrand | 80 | 2025-10-22 | 2026-01-05 |
| Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents Near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS) - Carotid Atherosclerosis, Carotid Artery Stenting | Not applicable | Completed | University Hospital, Motol | 52 | 2017-07-15 | 2020-04-29 |
| Search for Restenosis Markers in Lower Limb Arteritis To look for serum microRNA profiles associated with restenosis - Restenosis, Lower Limb Arteritis | Not applicable | Withdrawn | Centre Hospitalier Universitaire, Amiens | 2017-06-20 | 2017-07-21 | |
| Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions SeQuent Please OTW, Eluvia Vascular Stent System, Nitinol stent - Stenosis, Occlusion | Not applicable | Completed | InnoRa GmbH | 224 | 2017-03-30 | 2024-02-15 |
| Local Paclitaxel or Balloon Angioplasty Below the Knee SequentPlease OTW paclitaxel coated balloon catheter, conventional uncoated balloon for BTK endovascular therapy - Stenosis, Occlusion | Not applicable | Unknown | Prof. Dr. med. Gunnar Tepe | 120 | 2016-12-15 | 2017-05-11 |
| Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) Covera(TM) Vascular Covered Stent - Stenosis, Restenosis | Not applicable | Completed | C. R. Bard | 110 | 2016-07-01 | 2020-04-14 |
| Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft Covera Vascular Covered Stent following PTA, Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon - Stenosis, Restenosis | Not applicable | Completed | C. R. Bard | 280 | 2016-06-01 | 2021-12-21 |
| Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis Lutonix DCB, Standard Uncoated Balloon Angioplasty Catheter - Femoral Artery Stenosis, Femoral Artery Occlusion | Not applicable | Completed | C. R. Bard | 82 | 2014-03-01 | 2019-04-11 |
| OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA TAXUS™ Element long stent - Coronary Heart Disease, Diabetes | Not applicable | Completed | Centre Chirurgical Marie Lannelongue | 300 | 2012-10-01 | 2020-01-23 |
| JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions JetStream Navitus - Restenosis, Peripheral Vascular Disease | Not applicable | Completed | Midwest Cardiovascular Research Foundation | 29 | 2012-10-01 | 2020-03-03 |
| Treatment of Coronary In-Stent Restenosis paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus, seal-wing paclitaxel-eluting balloon catheter - Restenosis | Not applicable | Completed | University Hospital Ostrava | 199 | 2012-01-01 | 2022-12-08 |
| Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention Paclitaxel, Placebo - Restenosis, Peripheral Arterial Disease | Not applicable | Unknown | Midwest Cardiovascular Research Foundation | 100 | 2012-01-01 | 2012-05-15 |
| Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems - Restenosis | Not applicable | Unknown | Herz-Zentrums Bad Krozingen | 50 | 2011-04-01 | 2011-02-21 |
| FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis Fluency Plus Endovascular Stent Graft, Percutaneous Transluminal Angioplasty only - Restenosis | Not applicable | Completed | C. R. Bard | 275 | 2010-12-01 | 2017-01-09 |
| Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis Insulin - Restenosis, Tight Glycemic Control | Not applicable | Completed | University of Campania Luigi Vanvitelli | 200 | 2009-12-01 | 2011-12-21 |
| SEDUCE OCT Study in Coronary Artery rEstenosis:an Optical Coherence Tomography (OCT) Study Sequent Please Paclitaxel eluting balloon, Xience V everolimus eluting stent - Restenosis | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 50 | 2009-05-01 | 2023-01-27 |
| Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis Spectranetics Laser with adjunct PTA and Gore VIABAHN Endoprosthesis with Heparin Bioactive Surface - Restenosis | Not applicable | Terminated | VIVA Physicians | 27 | 2007-11-01 | 2014-06-04 |
Constriction, Pathologic (4) · Bites and Stings (2) · Chronic Limb-Threatening Ischemia (2) · Coronary Artery Disease (2) · Kidney Failure, Chronic (2) · Peripheral Arterial Disease (2) · Arteriovenous Fistula (1) · Carotid Artery Diseases (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Hyperglycemia (1) · Insulin Resistance (1) · Peripheral Vascular Diseases (1) · Plaque, Atherosclerotic (1)
Cardiovascular Diseases (9) · Vascular Diseases (9) · Pathological Conditions, Signs and Symptoms (6) · Arterial Occlusive Diseases (5) · Arteriosclerosis (5) · Pathological Conditions, Anatomical (5) · Chronic Disease (4) · Disease Attributes (4) · Pathologic Processes (4) · Atherosclerosis (3) · Heart Diseases (3) · Myocardial Ischemia (3) · Peripheral Vascular Diseases (3) · Chemically-Induced Disorders (2) · Coronary Disease (2)
Angioplasty (1) · Drug-Eluting Stents (1) · Insulin (1) · Paclitaxel (1) · Spectroscopy, Near-Infrared (1)
C. R. Bard (4) · Midwest Cardiovascular Research Foundation (2) · Centre Chirurgical Marie Lannelongue (1) · Centre Hospitalier Universitaire, Amiens (1) · Hamilton Health Sciences Corporation (1) · Herz-Zentrums Bad Krozingen (1) · InnoRa GmbH (1) · Prof. Dr. med. Gunnar Tepe (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Hospital Ostrava (1) · University Hospital, Clermont-Ferrand (1) · University Hospital, Motol (1) · University of Campania Luigi Vanvitelli (1) · VIVA Physicians (1)
United States (7) · Austria (3) · France (3) · Germany (3) · Belgium (2) · Czechia (2) · Australia (1) · Canada (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Switzerland (1)
Bart Dolmatch, M.D. (2) · Gunnar Tepe, MD (2) · Abigail Falk, M.D. (1) · Alexander Yevzlin, MD (1) · Carlos Mena, MD (1) · Eric J Dippel, MD (1) · Ivan Maya, MD (1) · Leos Pleva, M.D. (1) · Nicolas W Shammas, MD, MS (1) · Raffaele Marfella, MD, PhD (1) · Tom Adriaenssens, MD (1) · Tony Das, MD (1) · Walter Desmet, MD, PhD (1)
PMID 14993129, PMID 15172398, PMID 19228612, PMID 22639289, PMID 23876463, PMID 25138182, PMID 26921281, PMID 27069104, PMID 28651572, PMID 30019843, PMID 35070788, PMID 36990214, PMID 42573020